NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 37 of 37 results found.

Activity Company Description Location
Company Acclivity Technologies Inc. Activity: Research and Development Research and Development Company Description Acclivity is a virtual pharma company developing novel small molecule therapeutics for treatment of peripheral artery disease and other cardiovascular, inflammatory and ischemic disease indications, vasculitis and type 2 diabetes. Location Raleigh
Company AimMax Therapeutics Inc. Activity: Research and Development Research and Development Company Description AimMax Therapeutics researches and develops biopharmaceuticals for the treatment of infection, inflammation and pain through in-licensing or co-development with strategic partners. Location Durham
Company Allergy Partners Extract Laboratory Activity: Production and Manufacturing Production and Manufacturing Company Description Allergy Partners' Extract Laboratory produces extracts that are used to treat allergic disease, asthma and immunology. Location Asheville
Company ALP Life Sciences Inc. Activity: Research and Development Research and Development Company Description ALP Life Sciences has formulated and markets a High-3 fish oil supplement to increase omega-3 absorption and bioavailability for the treatment of fatty liver disease and inflammatory diseases. Location Black Mountain
Company Altavera Analytics Activity: Contract Research and Testing Contract Research and Testing Company Description Altavera Analytics provides custom solutions for bioinformatics, utilizing cloud-based workflows and statistical analysis of genomic data. Altavera specializes in biomedicine, including immunology and neurology, as well as agricultural applications, including plant molecular biology and CRISPR screens. Location Durham
Company Antigenomycs Inc. Activity: Research and Development Research and Development Company Description Antigenomycs is commercializing antigenome technology to measure complex antibody responses in health and disease. Location Durham
Company Areteia Therapeutics Inc. Activity: Research and Development Research and Development Company Description Areteia Therapeutics is developing the first oral drug for eosinophilic asthma. Location Chapel Hill
Company Attagene Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description Attagene has developed a pathway profiling technology to evaluate the impact of pharmaceuticals, environmental chemicals and natural products on over 100 transcription factors and 48 nuclear receptors. Location Morrisville
Company Avicenna Biosciences Inc. Activity: Research and Development Research and Development Company Description Avicenna Biosciences is a drug development company using machine learning-enhanced medicinal chemistry to accelerate the lead-to-candidate optimization process for small molecule drug development. Location Durham
Company Belhaven Biopharma Inc. Activity: Research and Development Research and Development Company Description Belhaven Biopharma is developing dry powder nasal products for a variety of indications. Location Raleigh
Company Bio Products Laboratory USA Inc. Activity: Sales and Operations Sales and Operations Company Description Bio Products Laboratory (BPL) manufactures and distributes plasma-derived products, including intravenous immunoglobulin preparations, coagulation factors and albumin solution. U.S. Commercial Operations for BPL are based in Durham. Location Durham
Company Bryn Pharma LLC Activity: Research and Development Research and Development Company Description Bryn Pharma is developing a nasal solution for the administration of emergency epinephrine for the treatment of anaphylaxis. Location Raleigh
Company Cellective BioTherapy Inc. Activity: Research and Development Research and Development Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. Location Chapel Hill
Company Cloud Pharmaceuticals Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description Cloud Pharmaceuticals designs and develops novel drug molecules using computational design for a wide range of therapeutic areas including cancer, inflammation, CNS disorders and rare diseases. Location Research Triangle Park
Company Cognosci Inc. Activity: Research and Development Research and Development Company Description Cognosci develops neurorestorative therapies for Alzheimer's disease, multiple sclerosis, traumatic brain injury, nerve crush and other disease and trauma indications. Location Durham
Company CytexOrtho Activity: Research and Development Research and Development Company Description CytexOrtho develops bio-artificial devices to treat osteoarthritis and other musculoskeletal diseases. Location Durham
Company Diabetic Health Inc. Activity: Research and Development Research and Development Company Description Diabetic Health develops coatings to improve the longevity and performance of continuous glucose monitoring sensors (CGM) and insulin infusion sets used in diabetes management. Location Research Triangle Park
Company Emergo Therapeutics Inc. Activity: Research and Development Research and Development Company Description Emergo Therapeutics develops drugs to reduce the production of inflammatory cytokines from mast cells and improve the functioning of the immune system in various potential indications, starting with infectious diseases. Location Durham
Company Endacea Inc. Activity: Research and Development Research and Development Company Description Endacea develops A1 adenosine receptor antagonists as drug candidates for cancer, COVID-19 acute lung injury, sepsis and acute renal failure. Location Research Triangle Park
Company EydisBio Inc. Activity: Research and Development Research and Development Company Description Eydis Bio is developing a platform of small molecule therapeutics targeting a variety of diseases driven by aberrant inflammatory/autoimmune processes. Location Durham
Company Genencine Therapeutics LLC Activity: Research and Development Research and Development Company Description Genencine Therapeutics develops mRNA vaccines for the prevention and treatment of cancer, viral diseases and autoimmune diseases, as well as mRNA therapeutic drugs for genetic diseases. Location Durham
Company Global Vaccines Inc. Activity: Research and Development Research and Development Company Description Global Vaccines is a not-for-profit company that develops vaccines against developing-country diseases such as HIV/AIDS, polio, dengue fever, malaria and viral diarrhea (rotavirus). Location Chapel Hill
Company Gusto Global LLC Activity: Research and Development Research and Development Company Description Gusto Global is developing a discovery platform that integrates advanced computational and lab-based discovery tools to develop next-generation microbiome-based therapeutics & diagnostics. Location Research Triangle Park
Company Hudson Therapeutics Inc. Activity: Research and Development Research and Development Company Description Hudson Therapeutics, a subsidiary of Shaperon Inc., conducts global clinical trials and business development for anti-inflammatory and immunology drugs. Location Research Triangle Park
Company Immorna Biotherapeutics Inc. Activity: Research and Development Research and Development Company Description Immorna Biotherapeutics develops self-replicating and conventional mRNA-based therapeutics and vaccines. Location Raleigh
Company Immunovant Inc. Activity: Research and Development Research and Development Company Description Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases. Location Durham
Company IMMvention Therapeutix Inc. Activity: Research and Development Research and Development Company Description IMMvention develops small molecule therapies that inhibit multiple inflammasome receptors to treat both rare and prevalent inflammatory diseases. Location Research Triangle Park
Company Kaio Therapy LLC Activity: Research and Development Research and Development Company Description KAIO Therapy develops an immunotherapy technology to treat solid tumors. Location Raleigh
Company Mastezellen Bio Inc. Activity: Research and Development Research and Development Company Description Mastezellen Bio is developing therapeutics for the treatment of diseases and disorders with mast cell involvement. Location Research Triangle Park
Company Mizar Therapeutics Activity: Research and Development Research and Development Company Description Mizar Therapeutics is a platform therapeutics company that provides drug discovery services using proprietary live-cell single-molecule imaging and machine-learning technology. Location Chapel Hill
Company Mucommune LLC Activity: Research and Development Research and Development Company Description Mucommune is developing a platform using monoclonal antibodies and mucus to reinforce the mucus barrier for female reproductive health. Location Durham
Company North Carolina Clinical Research Activity: Contract Research and Testing Contract Research and Testing Company Description North Carolina Clinical Research conducts phase 1 through 4 trials at its outpatient clinical research facility. Study indications include allergy (seasonal and perennial), asthma, COPD, vaccine, migraine, bioequivalent studies and celiac disease. Location Raleigh
Company Priovant Therapeutics Activity: Research and Development Research and Development Company Description Priovant is developing and commercializing targeted therapeutics for patients with severe autoimmune disease. Location Durham
Company Qura Therapeutics LLC Activity: Research and Development Research and Development Company Description Qura Therapeutics is discovering therapeutics for curing HIV/AIDS. Qura is a joint venture between ViV Healthcare and UNC-CH and provides financial, material and development support for therapies that emerge from research at the UNC HIV Cure Center. Location Chapel Hill
Company Renovion Inc. Activity: Research and Development Research and Development Company Description Renovion is a clinical stage company developing therapies for chronic inflammatory lung diseases, including bronchiectasis, BOS in lung transplant and chronic bronchitis. Location Chapel Hill
Company TregTherapeutics Inc. Activity: Research and Development Research and Development Company Description TregTherapeutics develops tolerogenic therapies to treat autoimmune disease. The approach uses endogenous antigens to personalize therapy for any patient and/or disease. Location Chapel Hill
Company vTv Therapeutics LLC Activity: Research and Development Research and Development Company Description vTv Therapeutics is a clinical-stage biopharmaceutical company developing orally administered small molecule drug candidates to fill significant unmet medical needs in Alzheimer's disease (AD), diabetes and inflammatory disorders. Location High Point